Mometasone Sandoz (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors in the cells lining the nasal passages. This interaction triggers the production of anti‑inflammatory proteins and suppresses the release of cytokines that cause swelling and mucus, thereby reducing nasal inflammation and improving airflow.

The exact dosing regimen for Mometasone Sandoz is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms and clinical response. Typical adult dosing may involve one or two sprays per nostril once daily, but the prescriber’s instructions must be followed.

The safety of mometasone furoate in pregnancy and lactation has not been definitively established, and it is classified as a pregnancy category with unknown risk. Healthcare providers should weigh the potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Mometasone Sandoz. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone furoate is a high‑potency intranasal corticosteroid with a low systemic absorption profile, similar to fluticasone propionate and budesonide. Clinical studies show comparable efficacy in reducing allergic rhinitis symptoms, while its once‑daily dosing and favorable safety record make it a convenient option for many patients.

Store the nasal spray at room temperature, below 25 °C, in its original packaging. Protect it from moisture, excessive heat and direct sunlight. Do not freeze the product, and keep the cap tightly closed when not in use to maintain spray performance.

Shake the bottle gently, remove the protective cap, and prime the spray if it is the first use. Tilt the head slightly forward, insert the tip into one nostril, and press the actuator while breathing in gently through the nose. Repeat the prescribed number of sprays in each nostril and avoid blowing the nose for several minutes afterward.

Serious but rare risks include nasal septal perforation, secondary fungal or bacterial sinus infections, and systemic adrenal suppression when used at high doses for prolonged periods. Patients should report persistent nosebleeds, unusual eye discomfort or signs of infection promptly to their healthcare provider.

Mometasone Sandoz should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients with active untreated nasal or sinus infections, recent nasal surgery or trauma, and in those for whom systemic corticosteroid therapy is contraindicated.